South and Central America Tissue Sectioning Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product [Instruments (Rotary Microtome, Ultramicrotome, Cryostat, Sliding Microtome, and Others), Accessories and Consumables, and Services], Technology (Automatic, Semiautomatic, and Manual), Application (Diagnosis, and Research), and End User (Hospitals, Clinics, Diagnostic Laboratories, Digital Path Labs, and Others)
Market Introduction
Tissue sectioning is a procedure that involves cutting tissues into thin sections so that they can be placed on a slide and then mounted under a microscope for study. It is used to examine tissue in order to detect any abnormalities or disease conditions. It is employed in histology laboratories, science laboratories, and other settings. Tissue processing is carried out after it has been examined between tissue embedding and fixation. Frozen sectioning and paraffin sectioning are the two types of tissue sectioning. It is used to detect breast nodules to determine whether a mastectomy is necessary, as well as to treat congenital megacolon in children and newborns. For advanced analysis, the tissues to be sectioned must be cut into very thin pieces or sections, i.e., 5-10 micrometer or smaller portions.
Get more information on this report : 
Market Overview and Dynamics
The South and Central America tissue sectioning market is expected to reach US$ 52.63 million by 2028 from US$ 35.85 million in 2021. It is estimated to grow at a CAGR of 5.6% from 2021 to 2028. The increasing prevalence of chronic diseases and the rising adoption of personalized medicines are propelling this regional market. However, the lack of skilled professionals is expected to restrict the market growth during the forecast period.
Under the Ministry of Health and Family Welfare (MoHFW) and the Government of India, the NHM backed all states to provide essential diagnostics at their public health installations free of cost in India. Taking this initiative to global position, the WHO released the original edition of the Essential Diagnostics List (EDL) in May 2018. Fastening on the significance of diagnosis, the WHO stated the testing affects the majority of medical opinions. Appropriate diagnostic tests can inform evidence-based treatment and accountable use of medicines, performing in the overall bettered allocation of resources and better health outcomes.
With a remarkable rise in the aging population, several chronic ailments cases are showing an increase, leading to the necessity toward prevention and cure from a disorder, and, hence, the medical decision. Tissue sectioning (including necropsies, surgical or necropsy samples) is a core part of histopathological examinations, on which the physicians can blindly rely for the result accuracy. The superficial tissue sections may not represent the whole necropsy, which leads to repeated requests for deeper sections to enhance sensitivity and diagnostic delicacy. The data mentioned above and factors are performing in an increase in the number of remedial establishments. For illustration, pathology laboratories and clinics have increased the appropriation of tissue sectioning. These developments and rapid adoption are shifting the focus of pathologists and researchers toward exploring other approaches. Also, this massive contribution to ineffective treatments with the aid of histopathological examination is a significant factor in the growth of the tissue sectioning market.
South and Central America has been witnessing a significant number of COVID-19 cases; the increasing number of cases in Brazil, Peru, Chile, Ecuador, and Venezuela is likely to impact the market negatively. A considerable number of countries in South America have very underdeveloped healthcare infrastructure. For instance, Peru has less than 1000 intensive care unit beds for its 32 million inhabitants. Furthermore, supply chain disruption caused due to congestion of ports and disturbances in other transport means had a substantial impact on the distribution of associated devices in the region. As the focus on COVID-19 patients became critical, the non-urgent medical procedures took a back seat. Several clinics have postponed or dropped numerous elective surgeries, especially those considered non-urgent. The markets associated with tissue sectioning, such as histopathological diagnosis, would be severely affected. All these factors considerably deterred the growth of the South and Central America tissue sectioning market. However, the number of tissue sections again started to gain momentum as the number of COVID-19 confirmations declined.
Key Market Segments
Based on the product, the South and Central America tissue sectioning market is segmented into instruments, accessories & consumables, and services. The instruments segment is further sub-segmented into rotary microtome, ultramicrotome, cryostat, sliding microtome, and others. In 2021, the instruments segment held the largest share of the market. The accessories and consumables segment is expected to grow at the fastest CAGR during the forecast period.
Based on the technology, the South and Central America tissue sectioning market is segmented into automatic, semiautomatic, and manual. The automatic technology segment held the largest share of the market in 2021, and the same segment is estimated to register the highest CAGR in the market during the forecast period.
Based on the application, The South and Central America tissue sectioning market is segmented into diagnosis and research. In 2021, the diagnosis segment accounted for the largest share of the market. The research segment is expected to witness the fastest CAGR from 2021 to 2028.
Based on the end user, the South and Central America tissue sectioning market is segmented into hospitals, clinics, diagnostic laboratories, digital path labs, and others. In 2021, the hospitals segment led the global market. However, the diagnostic laboratories segment is expected to report the fastest CAGR from 2021 to 2028.
Major Sources and Companies Listed
Some of the primary and secondary sources associated with this report on the South and Central America tissue sectioning market are the Center for Disease Control and Prevention (CDC) and Pharmaceutical Research and Manufacturers Association (PhRMA).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of South and Central America tissue sectioning market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the South and Central America tissue sectioning market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the South and Central America tissue sectioning market.
SOUTH AND CENTRAL AMERICA TISSUE SECTIONING MARKET SEGMENTATION
By Product
- Instruments
- Rotary Microtome
- Ultramicrotome
- Cryostat
- Sliding Microtome
- Others
- Accessories and Consumables
- Services
By Technology
- Automatic
- Semi-Automatic
- Manual
By Application
- Diagnosis
- Research
By End User
• Hospitals
• Clinics
• Diagnostic Laboratories
• Digital Path Labs
- Others
By Country
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- THERMO FISHER SCIENTIFIC, INC.
- Leica Biosystems Nussloch GmbH (Danaher)
- Diapath S.p.A
- MEDITE Medical GmbH
- Abcam Plc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Tissue Sectioning Market – By Product
1.3.2 South and Central America Tissue Sectioning Market – By Technology
1.3.3 South and Central America Tissue Sectioning Market – By Application
1.3.4 South and Central America Tissue Sectioning Market – By End User
1.3.5 South and Central America Tissue Sectioning Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Tissue Sectioning Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America PEST Analysis
4.3 Experts Opinion
5. Tissue Sectioning Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Adoption of Personalized Medicine
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Rising Government Support for Diagnostic’s Research & Development
5.4 Future Trends
5.4.1 Increasing Popularity of Robots & Automation in Healthcare
5.5 Impact Analysis
6. Tissue Sectioning Market–South and Central America Analysis
6.1 South and Central America Tissue Sectioning Market Revenue Forecast and Analysis
7. Tissue Sectioning Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 Tissue Sectioning Market Share by Product 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)
7.3.3 Rotary Microtome
7.3.3.1 Overview
7.3.3.2 Rotary Microtome Market Revenue and Forecast to 2028 (US$ Million)
7.3.4 Ultramicrotome
7.3.4.1 Overview
7.3.4.2 Ultramicrotome Market Revenue and Forecast to 2028 (US$ Million)
7.3.5 Cryostat
7.3.5.1 Overview
7.3.5.2 Cryostat Market Revenue and Forecast to 2028 (US$ Million)
7.3.6 Sliding Microtome
7.3.6.1 Overview
7.3.6.2 Sliding Microtome Market Revenue and Forecast to 2028 (US$ Million)
7.3.7 Others
7.3.7.1 Overview
7.3.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
7.4 Accessories and Consumables
7.4.1 Overview
7.4.2 Accessories and Consumables Market Revenue and Forecast to 2028 (US$ Million)
7.5 Services
7.5.1 Overview
7.5.2 Services Market Revenue and Forecast to 2028 (US$ Million)
8. Tissue Sectioning Market Analysis – By Technology
8.1 Overview
8.2 Tissue Sectioning Market Share, by Technology, 2021 and 2028 (%)
8.3 Automatic
8.3.1 Overview
8.3.2 Automatic: Tissue Sectioning Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Semi-Automatic
8.4.1 Overview
8.4.2 Semi-Automatic: Tissue Sectioning Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Manual
8.5.1 Overview
8.5.2 Manual: Tissue Sectioning Market– Revenue and Forecast to 2028 (US$ Million)
9. Tissue Sectioning Market Revenue and Forecasts To 2028 – Application
9.1 Overview
9.2 Tissue Sectioning Market Share by Application - 2021 & 2028 (%)
9.3 Diagnosis
9.3.1 Overview
9.3.2 Diagnosis: Tissue Sectioning Market Revenue and Forecast to 2028 (US$ Million)
9.4 Research
9.4.1 Overview
9.4.2 Research: Tissue Sectioning Market Revenue and Forecast to 2028 (US$ Million)
10. Tissue Sectioning Market Revenue and Forecasts To 2028 – End User
10.1 Overview
10.2 Tissue Sectioning Market Share by End User - 2021 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Tissue Sectioning Market Revenue and Forecast to 2028 (US$ Million)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Tissue Sectioning Market Revenue and Forecast to 2028 (US$ Million)
10.5 Diagnostic Laboratories
10.5.1 Overview
10.5.2 Diagnostic Laboratories: Tissue Sectioning Market Revenue and Forecast to 2028 (US$ Million)
10.6 Digital Path Labs
10.6.1 Overview
10.6.2 Digital Path Labs: Tissue Sectioning Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Tissue Sectioning Market Revenue and Forecast to 2028 (US$ Million)
11. Tissue Sectioning Market Revenue and Forecasts to 2028 – South and Central America Analysis
11.1 South and Central America Tissue Sectioning Market Revenue and Forecasts To 2028
11.1.1 Overview
11.1.2 South and Central America: Tissue Sectioning Market – Revenue and Forecast to 2028 (USD Million)
11.1.3 South and Central America: Tissue Sectioning Market, by Product, 2019–2028 (USD Million)
11.1.3.1 South and Central America: Tissue Sectioning Market for Instruments, by Product, 2019–2028 (USD Million)
11.1.4 South and Central America: Tissue Sectioning Market, By Technology, 2019–2028 (USD Million)
11.1.5 South and Central America: Tissue Sectioning Market, by Application, 2019–2028 (USD Million)
11.1.6 South and Central America: Tissue Sectioning Market, by End User, 2019–2028 (USD Million)
11.1.7 South and Central America: Tissue Sectioning Market, by Country, 2021 & 2028 (%)
11.1.7.1 Brazil: Tissue Sectioning Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 Brazil: Tissue Sectioning Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 Brazil: Tissue Sectioning Market, by Product, 2019–2028 (USD Million)
11.1.7.1.2.1 Brazil: Tissue Sectioning Market for Instruments, by Product, 2019–2028 (USD Million)
11.1.7.1.3 Brazil: Tissue Sectioning Market, By Technology, 2019–2028 (USD Million)
11.1.7.1.4 Brazil: Tissue Sectioning Market, by Application, 2019–2028 (USD Million)
11.1.7.1.5 Brazil: Tissue Sectioning Market, by End User, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on South and Central America Tissue Sectioning Market
12.1 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Tissue Sectioning Market–Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 THERMO FISHER SCIENTIFIC, INC.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Leica Biosystems Nussloch GmbH (Danaher)
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Diapath S.p.A.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MEDITE Medical GmbH
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Abcam Plc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America: Tissue Sectioning Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. South and Central America: Tissue Sectioning Market for Instruments, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. South and Central America: Tissue Sectioning Market, By Type – Technology and Forecast to 2028 (USD Million)
Table 4. South and Central America: Tissue Sectioning Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. South and Central America: Tissue Sectioning Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 6. Brazil: Tissue Sectioning Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 7. Brazil: Tissue Sectioning Market for Instruments, by Product – Revenue and Forecast to 2028 (USD Million)
Table 8. Brazil: Tissue Sectioning Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 9. Brazil: Tissue Sectioning Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Brazil: Tissue Sectioning Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 11. Recent Inorganic Growth Strategies in the Tissue Sectioning Market
Table 12. Recent Organic Growth Strategies in the Tissue Sectioning Market
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. Tissue Sectioning Market Segmentation
Figure 2. Tissue Sectioning Market, By Country
Figure 3. South and Central America Tissue Sectioning Market Overview
Figure 4. Automatic Segment Held Largest Share of Technology Segment in Tissue Sectioning Market
Figure 5. South and Central America Tissue Sectioning Market- Leading Country Markets (US$ Million)
Figure 6. South and Central America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Tissue Sectioning Market: Impact Analysis of Drivers and Restraints
Figure 9. South and Central America Tissue Sectioning Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 10. Tissue Sectioning Market Share by Product 2021 & 2028 (%)
Figure 11. Instruments Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Rotary Microtome Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Ultramicrotome Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Cryostat Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Sliding Microtome Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Others Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Accessories and Consumables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Services Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Tissue Sectioning Market Share, by Technology, 2021 and 2028 (%)
Figure 20. Automatic: Tissue Sectioning Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Semi-Automatic: Tissue Sectioning Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Manual: Tissue Sectioning Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Tissue Sectioning Market Share by Application - 2021 & 2028 (%)
Figure 24. Diagnosis: Tissue Sectioning Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Research: Tissue Sectioning Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Tissue Sectioning Market Share by End User - 2021 & 2028 (%)
Figure 27. Hospitals: Tissue Sectioning Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Clinics: Tissue Sectioning Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Diagnostic Laboratories: Tissue Sectioning Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Digital Path Labs: Tissue Sectioning Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Others: Tissue Sectioning Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. South and Central America: Tissue Sectioning Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. South and Central America Tissue Sectioning Market Revenue and Forecast to 2028 (USD Million)
Figure 34. South and Central America: Tissue Sectioning Market, by Country, 2021 & 2028 (%)
Figure 35. Brazil: Tissue Sectioning Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Impact of COVID-19 Pandemic in South and Central American Countries
- THERMO FISHER SCIENTIFIC, INC.
- Leica Biosystems Nussloch GmbH (Danaher)
- Diapath S.p.A
- MEDITE Medical GmbH
- Abcam Plc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America tissue sectioning market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America tissue sectioning market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.